Price target
71.250.000.00%
The 4 analysts offering 1 year price forecasts for 0QNA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 0QNA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0QNA EPS for the last quarter is 1.61 CHF despite the estimation of 1.17 CHF. In the next quarter EPS is expected to reach 2.48 CHF. Track more of BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financials and stay on top of what is up with the company.
In the next quarter BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) revenue is expected to reach 123.50 M CHF. Check out BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) revenue and earnings and make informed decisions.
According to analysts, 0QNA price target is 71.25 CHF with a max estimate of 100.00 CHF and a min estimate of 52.00 CHF. Check if this forecast comes true in a year, meanwhile watch BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) stock price chart and keep track of the current situation with 0QNA news and stock market news.
We've gathered opinions of 5 analysts rating 0QNA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.